Pharming outlines $405M–$425M 2026 revenue target as Joenja and RUCONEST drive growth
Pharming Group N.V. ADS, each representing 10 ordinary shares · Now $13.10
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS